SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical
NKTR Drug delivery Company
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
497 37 0 NKTR
Emcee:  david nordic Type:  Unmoderated
Subject 11419

Nektar Therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform.

Cancer and Pain Products
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
497finance.yahoo.com Stephen Doberstein (chief-R&D, 181-inventor) is gently pMiljenko Zuanic-October 1
496secfilings.nasdaq.com Why took him so long? Well, better ever than never...Miljenko Zuanic-September 10
495Thanks Julius for complete institutions ownership report. I was rounding INVESCOMiljenko Zuanic-September 7
494 Holder Shares Date Reported % Out Value Invesco Ltd. 23,343,019 Jun 29, 201Julius Wong-September 7
493I did not commented early on this,... for 2Q INVESCO Ltd increased position by 2Miljenko Zuanic-September 7
492Most likely there will be extension of the PDUFA, 3-6 months, and Adcom is very Miljenko Zuanic1August 28
491I guess technically I am not accurate in them saying it won't be met but howghmm-August 28
490So, it appears there is no 181 CRL and path to approval is intact. MrM need updMiljenko Zuanic-August 28
489FWIW they already announced PDUFA won't be met. That was CFO and he exerciseghmm-August 28
488Unbelievable—-the CEO dumps another 30,000 shares four days before the FDA is scArthur Radley-August 26
487What a waste of the options! SUCKERS!Miljenko Zuanic-August 19
486CFO nets another $250;000.00 by flipping a option conversion into shares and selArthur Radley-August 17
485Ah, well maybe they can amend that suit. Something to keep an eye on. Whatevertuck-August 9
484<Mildly surprised no class action suit has been filed yet.> "On OctobMiljenko Zuanic-August 9
483Arthur, I am as much frustrated as you are, or even more...because I did try toMiljenko Zuanic-August 9
482Tuck, Having now read the full transcript of the CC this fiasco is now coming iArthur Radley-August 9
481Mildly surprised no class action suit has been filed yet. But tomorrow's antuck-August 9
480Now we know why the CEO was unloading all those shares before this news came outArthur Radley-August 8
479MF Butcher Shop! investors.comMiljenko Zuanic-August 8
478What was a base (May15 to May31) for +3M share short increase? What changed (negMiljenko Zuanic-June 13
477Enrolment rate and centers opening rate for melanoma P3 still *confuse* all whatMiljenko Zuanic-June 4
476Shares are up nearly $3.00 per share in pre-market, so Wall Street must like thArthur Radley-June 3
475214 at ASCO-2019 nektar.comMiljenko Zuanic-June 1
474Regorafenib for osteosarcoma: ascopubs.orgMiljenko Zuanic-May 30
473That was my point/concern. And Mary mentioned on cc, only FEW more subjects to Miljenko Zuanic-May 16
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):